Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|November 7, 2009
Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's diseaseSadanand Gaikwad, Sergey Larionov, Yiner Wang, et al.
World Neurosurgery|June 1, 2014
Navigated high frequency ultrasound: description of technique and clinical comparison with conventional intracranial ultrasoundJan Coburger, Ralph W König, Angelika Scheuerle, et al.
Plos One|January 13, 2009
Immunohistochemical characterisation of cell-type specific expression of CK1delta in various tissues of young adult BALB/c miceJürgen Löhler, Heidrun Hirner, Bernhard Schmidt, et al.
Neuromuscular Disorders : NMD|September 7, 2020
Clinical and muscle MRI features in a family with tubular aggregate myopathy and novel STIM1 mutationThomas Claeys, Veerle Goosens, Valérie Racé, et al.
Journal of Neuropathology and Experimental Neurology|July 27, 2005
Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliabilityChristian M Müller, Rob A I de Vos, Claude-Alain Maurage, et al.
Acta Neurologica Belgica|January 30, 2020
Myositis as a neuromuscular complication of immune checkpoint inhibitorsLynn Vermeulen, Christophe E Depuydt, Petra Weckx, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2025
Spatial Atmospheric Pressure MALDI HRMS Analysis of Histological Sections of FFPE Samples Reveals a Unique Subset of the MetabolomeGilles Frache, David C Muddiman, Simona Ospitalieri, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 8, 2006
GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptideTina Wahle, Dietmar R Thal, Magdalena Sastre, et al.
Annals of Clinical and Translational Neurology|July 17, 2018
Modified amyloid variants in pathological subgroups of β-amyloidosisJanina Gerth, Sathish Kumar, Ajeet Rijal Upadhaya, et al.
Acta Neuropathologica|February 25, 2014
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelinationEnrique Garea Rodriguez, Christiane Wegner, Mario Kreutzfeldt, et al.
Pageof 10